A giant functional atlas of immune cells in a Chinese cohort reveals crucial differences with European and Japanese data sets ...

HOUSTON, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Marker Therapeutics, Inc. (Nasdaq: MRKR) is a clinical-stage immuno-oncology Company with the worldwide exclusive license of Multi-Antigen Targeted T cells ...

Marker Therapeutics (MRKR) is a clinical-stage immuno-oncology Company with the worldwide exclusive license of Multi-Antigen Targeted T cells, a ...

Researchers at the University of Southampton have developed a promising new way to bolster the body's immune system response to cancer.

Understanding why cancer cells rely on specific genes is critical for designing effective targeted therapies. A new study ...

A tiny microrobot enables the performance of precise movements, including grasping, delivering and releasing particles or cells, with applications in medicine, manufacturing and beyond. Microrobots ...

Clinical study from Baylor College of Medicine demonstrates a favorable safety profile and up to 84.6% disease control rate in patients with pancreatic cancer in Arm A of the clinical study Study ...